Purchase Order 75N91024P00295
- Not listed
- This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health, to Becton, Dickinson and Company (BD) for a service agreement to provide a FACSYMPHONY A5 spectral cell analyzer and high throughput sampler. The total ceiling value of the contract is $53,524.44 with a period of performance through December 12, 2025. This award is not associated with a set-aside program. BD is a global...
- The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $328,321.19 firm fixed price purchase order contract to Becton, Dickinson And Company BD Biosciences, Systems And Reagents Division for the purchase of one BD BIO FACSYMPHANY A3 Analyzer. The place of performance is San Jose, California and the period of performance is from August 8, 2022 through December 6, 2022. Becton, Dickinson And Company BD Biosciences, Systems And Reagents...
- The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $213,364.20 firm-fixed-price purchase order to Becton, Dickinson And Company (BD) for service and maintenance of a BD FACSymphony A3 flow cytometer located in San Jose, California. The contract has a completion date of February 29, 2024 and was awarded on February 26, 2019. The contract was not set aside for a specific business type. BD, a global medical technology company, provides a...
- The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Cancer Institute awarded a firm fixed-price purchase order to Becton, Dickinson and Company (BD) to acquire a BD FACSymphony A3 flow cytometer analyzer, a five-laser, 23-color system. The contract, which did not have a set-aside designation, was awarded on September 20, 2019 with a completion date of January 20, 2020 and a potential value of $359,443.75. BD Biosciences, a division of BD focused on...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm-fixed-price purchase order contract to Becton, Dickinson and Company (BD) for the supply of one FACSymphony A5 SORP & Fortessa System cell analyzer, valued at $574,988.05. The contract has no set-aside designation. BD is a global medical technology company that provides a wide range of equipment, reagents, and services to support biomedical research...
- The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a firm fixed price purchase order contract valued at $12,821.67 to Becton, Dickinson And Company (BD) for the acquisition of a 5-laser SORP cell analyzer instrument. This instrument is currently being used by all members of the EIB (likely referring to an internal NIH program) to prevent disruption of ongoing research experiments. The contract has a completion date of July 1, 2024. BD is a...
- This is a firm-fixed-price purchase order contract awarded by the Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases to Becton, Dickinson and Company (BD) for service and maintenance on FACS Symphony A5 equipment, HTS sampler, and lasers. The contract has a potential value of $184,752.92 and a completion date of March 31, 2023. No set-aside was used for this award. As the parent company, Becton, Dickinson and Company is a...
- This contract is a firm fixed price purchase order awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Neurological Disorders and Stroke (NINDS) to Becton, Dickinson and Company (BD), a global medical technology manufacturer. The purpose is to provide a maintenance and service agreement for BD's custom FACSYMPHONY A5 flow cytometer used by NINDS's Viral Immunology and Intravital Imaging Section. The contract has a potential value of...
- This is a $105,926.44 firm fixed-price delivery order awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health, to Becton, Dickinson and Company (BD) under the FSS-66 Scientific Equipment and Services federal supply schedule. The contract is for a SERVICE AGREEMENT with a period of performance through February 28, 2025. This delivery order is not a set-aside contract. BD is a global medical technology company that provides specialized equipment,...
- Becton, Dickinson and Company (BD) has been awarded a firm fixed price purchase order by the National Institutes of Health National Cancer Institute for $10,864.80. The contract calls for servicing an instrument used by approximately 75 personnel at the agency to conduct experiments involving costly reagents, animals, and extensive labor hours. Performance will take place in Bethesda, Maryland through April 2024. No set-aside designation was applied. This award is likely associated with...
This firm-fixed-price purchase order, awarded by the Department of Health and Human Services National Institutes of Health National Cancer Institute, is for a Service Agreement for the BD FACSymphony A3 Analyzer. The contract has a potential value of $10,909.26 and a completion date of July 1, 2024. The prime contractor is Becton, Dickinson And Company (BD), a global medical technology company that provides instruments, reagents, and services to support biomedical research and clinical applications. BD has extensive experience supporting U.S. government agencies, including the Department of Veterans Affairs, the National Institutes of Health, and the Department of Defense, through prime and subcontract awards to deliver specialized medical equipment, supplies, and laboratory services. This contract does not have a set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.9k | 3/21/24 |